Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 33 million vaccinations in female for HPV for the 13 countries covered in GlobalData’s epidemiology forecast. Currently, there are seven marketed vaccines, with Merck & Co being key player in the disease space. ... Read More
-
Vaccine Sales Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Investment in the Development of Vaccines to Boost Industry Growth ... Read More
-
Global Viral Vector Market Size study & Forecast, by Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), by Application (Cell & Gene Therapy, Vaccine, Biopharmaceutical & Pharmaceutical Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, CROs & CMOs) and Regional Analysis, 2023-2030
... Companies, Academics & Research Institutes, CROs & CMOs) and Regional Analysis, 2023-2030 Global Viral Vector Market is valued at approximately USD 3.10 billion in 2022 and is anticipated to grow with a healthy growth rate ... Read More
-
2023 Global Forecast for Nasal Vaccines Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Bacterial Vaccines Market
... Children), Adolescent Vaccines, Adult Vaccines, Geriatric Vaccines), By Distribution Channel (Government Agencies and Programs, Hospitals and Clinics, Retail Pharmacies, Online Pharmacies, Others), By Route of Administration (Injectable Vaccines, Oral Vaccines, Nasal Vaccines), By End-User (Healthcare ... Read More
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
... grow significantly. By 2028, it is projected to reach a value of USD 7.1 billion, showing a compound annual growth rate (CAGR) of 6.5% during the forecast period, starting from USD 5.2 billion in 2023. ... Read More
-
Veterinary Vaccines: Global Markets
... historical market revenues. Veterinary vaccines include designs and different technology along with applications. The product of veterinary vaccines are segmented into attenuated vaccine (live vaccine, modified live vaccine, live attenuated vaccine), inactivated vaccine, recombinant vaccine ... Read More
-
Needle-free Drug Delivery Technology Market by Product (Inhaler, Jet Injector, Novel Needles, Transdermal Patch, and Others), Application (Vaccine Delivery, Pain Management, Insulin Delivery, and Others), End User (Hospitals and Clinics, Homecare Settings
... and Others), and Region 2023-2028 The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a ... Read More
-
Global Peripheral Blood Mononuclear Cells Market Assessment, By Product [Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, PBMC Isolation & Viability Kits], By Application [Immunology, Hematology, Vaccine Development, Toxicology, Infectious Disease, others], By Techniques [Density Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F
... Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F The Global Peripheral Blood Mononuclear Cells (PBMCs) Market is projected to reach USD 273.28 million by 2030 from USD 589.84 million ... Read More
-
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 148 million vaccinations for PV in the adult population for the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there are seven leading marketed vaccines, with Merck & Co and Pfizer being key players in ... Read More
-
Nasal Vaccines Market
... pneumococcal, etc., Others (such as cholera, typhoid, etc.)), By End user (Pediatrics, Adults, Geriatrics, Others (such as travelers, military personnel, etc.), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & ... Read More
-
Cancer Vaccines Market Forecasts to 2028 – Global Analysis By Product Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines and Antigen/Adjuvant Cancer Vaccines), Application, End users and By Geography
... Application, End users and By Geography According to Stratistics MRC, the Global Cancer Vaccines Market is accounted for $7.50 billion in 2022 and is expected to reach $18.95 billion by 2028 growing at a CAGR ... Read More
-
2023 Global Forecast for Meningococcal Vaccine Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2023 Global Forecast for Medical Refrigerators For Vaccine Storage Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... over 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from ... Read More
-
Viral Vector Production Market By Viral Vector Type (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors), By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The viral vector production market was valued for $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, exhibiting a CAGR of 18.8% from 2023 to ... Read More
-
Inactivated Polio And Rabies Vaccines Market
... and Adults), by Distribution Channel (Government and Private) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 A vaccine consisting of ... Read More
-
Global Nanomedicine Market Assessment, By Nanomolecule Type [Nanoparticles (Polymer-Based, Lipid-Based, Nanocrystals, Inorganic, others), Nanoshells, Nanodevices, Nanotubes], By Application [Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others], By Disease Indication [Oncological Diseases, Infectious Diseases, Orthopaedic Diseases, Cardiovascular Diseases, Others], By Region, Opportunities, and Forecast 2016-2030F
... Cardiovascular Diseases, Others], By Region, Opportunities, and Forecast 2016-2030F Global Nanomedicine Market size was valued at USD 168.4 billion in 2022 which is expected to reach USD 319.72 billion in 2030 growing with a CAGR ... Read More
-
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... in GlobalData’s epidemiology fact sheet, GlobalData epidemiologists estimated a total of 66,674 incident cases of mpox in 2022. Tecovirimat (Tpoxx) is the only approved medication for the treatment of severe complications of mpox that is ... Read More
-
Pharmaceuticals Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs; Vaccines; Therapeutic Nutrients & Minerals; Substance Abuse And Addiction; Global Summary 2023
... & Minerals; Substance Abuse And Addiction; Global Summary 2023 Global pharmaceuticals market was worth $1596.4 billion in 2022. In terms of per capita consumption, the market was $204.6 and in terms of global GDP, the ... Read More
-
APAC Vaccine Packaging Market - Focused Insights 2023-2028
... and products are included in the report. Revenue generated by service providers are excluded from the scope of the report. This report provides a comprehensive and current market scenario of the APAC vaccine packaging, including ... Read More
-
Cancer Biologics Market (Drug Class: Monoclonal Antibodies (mAb), Recombinant Proteins, Cancer Growth Inhibitors, Vaccines, CAR-T Cells, Angiogenesis Inhibitors, Interleukins (IL), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global Cancer Biologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Vaccine Contract Manufacturing Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Global Demand, Product Innovation and Cost Effectiveness ... Read More
-
The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2024 Global Trade Perspective
... antisera, and other blood fractions. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the ... Read More
-
Animal Vaccines Market Share, Size, Trends, Industry Analysis Report, By Product (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines); By Type; By Disease; By Route of Administration; By Region; Segment Forecast, 2023 - 2032
... Region; Segment Forecast, 2023 - 2032 The global animal vaccines market size is expected to reach USD 31.07 billion by 2032, according to a new study by Polaris Market Research. The report “Animal Vaccines Market ... Read More
-
The World Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products: A 2024 Global Trade Perspective
... concerned with the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. With the globalization of this market, managers can no longer be contented with a local view. Nor can ... Read More